Adverse events · adults with functional dyspepsia
Proton pump inhibitors (PPI) showed no clear difference in adverse events compared with H2 receptor antagonists (H2RA) (moderate certainty).
1 finding from 1 review
Change (improvement) in disease severity (4 to 8 weeks) SMD (modified EASI score and SASSAD) · eczema
1 finding from 1 review
Adverse effects (4 to 6 weeks) · eczema
1 finding from 1 review
Corticosteroid requirements · eczema
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Reduction of pruritus · eczema
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Improvement in quality of life · eczema
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Need for emollient use · eczema
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Effect of long‐term control (> 3 months) · eczema
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects (4 to 8 weeks) · eczema
1 finding from 1 review
Corticosteroid requirements · eczema
1 finding from 1 review
Reduction of pruritus · eczema
1 finding from 1 review
Improvement in quality of life · eczema
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Need for emollient use · eczema
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change (improvement) in disease severity (4 weeks) SCORAD score · eczema
1 finding from 1 review
Effect of long‐term control (> 3 months) · eczema
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Death from any cause prior to hospital discharge · Neonates with PPHN
The intervention showed no clear difference in death from any cause prior to hospital discharge (low certainty).
1 finding from 1 review
RR 0.2 [0.02, 1.77]
37 participants
Low
Intervention not reported
Percentage of infants that showed improvement in OI by at least 20% by the end of therapy · Neonates with PPHN
1 finding from 1 review
no estimate extracted
39 participants
Low
Intervention not reported
Adverse neurological outcomes at six months of age · Neonates with PPHN
1 finding from 1 review
no estimate extracted
37 participants
Low
Intervention not reported
Cerebral Palsy · Neonates with PPHN
1 finding from 1 review
no estimate extracted
37 participants
Low
Intervention not reported
Deafness · Neonates with PPHN
1 finding from 1 review
no estimate extracted
37 participants
Low